Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Share on Pinterest Mounjaro, a tirzepatide drug prescribed ... in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss. For this study, researchers analyzed ...